Trial of Alvimopan in Major Spine Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Treatments for Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)
- Status
- COMPLETED
- Phase
- PHASE3
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)
- Status
- TERMINATED
- Phase
- PHASE2
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Reaching Better Health Study: A Website to Improve Type 2 Diabetes Self-Management
- Status
- COMPLETED
- Phase
- NA
A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
- Status
- COMPLETED
- Phase
- PHASE1